These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 10669640

  • 1. In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy.
    Higaki J, Aoki M, Morishita R, Kida I, Taniyama Y, Tomita N, Yamamoto K, Moriguchi A, Kaneda Y, Ogihara T.
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):428-34. PubMed ID: 10669640
    [Abstract] [Full Text] [Related]

  • 2. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.
    Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ.
    J Clin Invest; 1994 Sep; 94(3):978-84. PubMed ID: 8083382
    [Abstract] [Full Text] [Related]

  • 3. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JF, Apstein CS, Lorell BH.
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [Abstract] [Full Text] [Related]

  • 4. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy.
    Mukawa H, Toki Y, Shimauchi A, Matsui H, Morishima I, Okumura K, Ito T, Hayakawa T.
    J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751
    [Abstract] [Full Text] [Related]

  • 5. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro.
    Malhotra R, Sadoshima J, Brosius FC, Izumo S.
    Circ Res; 1999 Jul 23; 85(2):137-46. PubMed ID: 10417395
    [Abstract] [Full Text] [Related]

  • 6. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K, Moriyama S, Ishigai Y, Fukuzawa A, Irie K, Shibano T.
    Br J Pharmacol; 1994 Jul 23; 112(3):837-42. PubMed ID: 7921610
    [Abstract] [Full Text] [Related]

  • 7. Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.
    Morishita R, Gibbons GH, Tomita N, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Arterioscler Thromb Vasc Biol; 2000 Apr 23; 20(4):915-22. PubMed ID: 10764654
    [Abstract] [Full Text] [Related]

  • 8. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
    Zhao X, White R, Van Huysse J, Leenen FH.
    J Hypertens; 2000 Sep 23; 18(9):1319-26. PubMed ID: 10994763
    [Abstract] [Full Text] [Related]

  • 9. Small gene effect and exercise training-induced cardiac hypertrophy in mice: an Ace gene dosage study.
    Evangelista FS, Krieger JE.
    Physiol Genomics; 2006 Nov 27; 27(3):231-6. PubMed ID: 16926272
    [Abstract] [Full Text] [Related]

  • 10. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr 27; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats.
    Zhang LC, Li ZZ, Yu YS, Wang ZB, Wei X, Su DF, Li L.
    Biol Pharm Bull; 2011 Apr 27; 34(9):1398-403. PubMed ID: 21881224
    [Abstract] [Full Text] [Related]

  • 12. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
    Burrell LM, Gayed D, Griggs K, Patel SK, Velkoska E.
    PLoS One; 2017 Apr 27; 12(2):e0171975. PubMed ID: 28192475
    [Abstract] [Full Text] [Related]

  • 13. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
    Aoki M, Morishita R, Muraishi A, Moriguchi A, Sugimoto T, Maeda K, Dzau VJ, Kaneda Y, Higaki J, Ogihara T.
    J Mol Cell Cardiol; 1997 Mar 27; 29(3):949-59. PubMed ID: 9152856
    [Abstract] [Full Text] [Related]

  • 14. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy.
    Ruzicka M, Leenen FH.
    Circulation; 1995 Jan 01; 91(1):16-9. PubMed ID: 7805197
    [Abstract] [Full Text] [Related]

  • 15. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang S, Yin P, Ding Z, Kang L, Jiang Q, Zhang W, Li Y, Ge J, Zou Y.
    J Mol Cell Cardiol; 2016 Aug 01; 97():180-90. PubMed ID: 27210827
    [Abstract] [Full Text] [Related]

  • 16. Activation of the brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats.
    Nakamura S, Moriguchi A, Morishita R, Yamada K, Nishii T, Tomita N, Ohishi M, Kaneda Y, Higaki J, Ogihara T.
    Hypertension; 1999 Aug 01; 34(2):302-8. PubMed ID: 10454458
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.
    Ocaranza MP, Lavandero S, Jalil JE, Moya J, Pinto M, Novoa U, Apablaza F, Gonzalez L, Hernandez C, Varas M, Lopez R, Godoy I, Verdejo H, Chiong M.
    J Hypertens; 2010 May 01; 28(5):1054-64. PubMed ID: 20411619
    [Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P, Petrov V.
    J Mol Cell Cardiol; 1999 May 01; 31(5):949-70. PubMed ID: 10336836
    [Abstract] [Full Text] [Related]

  • 19. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P, Lavandero S.
    Hypertension; 2006 Oct 01; 48(4):572-8. PubMed ID: 16908757
    [Abstract] [Full Text] [Related]

  • 20. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
    Lear W, Ruzicka M, Leenen FH.
    Am J Physiol; 1997 Aug 01; 273(2 Pt 2):H641-6. PubMed ID: 9277479
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.